Gliflozins

Pharmacological aspects of the safety of gliflozins
CaMKII and GLUT1 in heart failure and the role of gliflozins
Ultrasound-assisted dispersive liquid–liquid microextraction for determination of three gliflozins in human plasma by HPLC/DAD
Postoperative euglycaemic diabetic ketoacidosis associated with sodium–glucose cotransporter-2 inhibitors (gliflozins): a report of two cases and review of the …
Meta-analyzing the factors affecting the efficacy of gliflozins in patients with heart failure based on heart failure trials
Gliflozins for the Treatment of Congestive Heart Failure and Renal Failure in Type 2 Diabetes
The good, the bad, and the ugly: sodium–glucose cotransporter-2 inhibitors (gliflozins) and perioperative diabetes
The synthesis of gliflozins
… II-induced upregulation of SGLT1 and 2 contributes to human microparticle‐stimulated endothelial senescence and dysfunction: protective effect of gliflozins
Long-term efficacy of gliflozins versus gliptins for Type 2 Diabetes after metformin failure: a systematic review and network meta-analysis
Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis
Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?
Analytical tools for determination of new oral antidiabetic drugs, glitazones, gliptins, gliflozins and glinides, in bulk materials, pharmaceuticals and biological …
SAVOR-TIMI to DECLARE-TIMI: A review on cardiovascular outcome trials of incretin-modulators and gliflozins
Are gliflozins the new statins for diabetes?
Metabolic effectiveness of gliflozins and gliptins in the routine clinical practice of patients with type 2 diabetes: preliminary results from GIOIA, a prospective multicentre …
Cardiovascular impact of new drugs (GLP-1 and gliflozins): the ABCD position statement
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
Gliflozins–a new border stone
euglycemic Diabetic Ketoacidosis In The Perioperative Period: Why Gliflozins May Not Be So Sweet After All!
Selecting Patients at Risk of Developing DKA on Gliflozins
PDB91-EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM
A review on analytical methods for determination of oral anti-diabetic drugs like biguanides, gliptins and gliflozins in bulk and in pharmaceutical dosage forms
Pharmacological characterization of the sodium-glicose co-transporter 2 inhibitors, gliflozins in isolated platelets from healthy volunteers
Article Details summary of chromatographic analysis methods of anti diabetic gliflozins Empagliflozin, Canagliflozin and Dapagliflozin
Gliflozins: initial review of literature
Summary of chromatographic analysis methods of anti diabetic gliflozins Empagliflozin, Canagliflozin and Dapagliflozin
How we indicate oral antidiabetics today (from metformin to gliptins and gliflozins)
Antidiabetic drugs from group of gliflozins and their role in pharmacotherapy of diabetes
Cardiorenal protection with SGLT2 inhibitors (gliflozins): from EMPA-REG OUTCOME to CANVAS

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Gliflozins

Dna Repair Via Flavonoids & Polyphenols

Insulin & Obesity

Extinction Training